Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Alaunos Therapeutics, Inc. (NASDAQ: TCRT)
TCRT Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-92.40%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
TCRT Stock Analysis
TCRT
PE Ratio:
TCRT
PEG Ratio:
Not Available
TCRT
Forward EPS Growth (12 month):
0.00%
TCRT
PS Ratio:
2132.8
TCRT
PSG Ratio:
Not Available
TCRT
Forward Revenue Growth (12 month):
0.00%
TCRT Articles
No data was found